Search Results
10
Everything
Search Filters
Tag
Pain
[Latest] Global Elastomeric Infusions Pumps Market Size/Share Worth USD 1,369.81 Million by 2034 at a 7.28% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
March 20, 2025 15:30 ET
|
Custom Market Insights
Austin, TX, USA, March 21, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Elastomeric Infusions Pumps Market Size, Trends and Insights By Product...
Dogwood Therapeutics, Inc. Announces Pricing of $4.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
March 13, 2025 09:00 ET
|
Dogwood Therapeutics, Inc.
Proceeds from today’s financing, when added to existing cash, fund operations through Q1 2026 The Company is planning to announce interim data from its ongoing Halneuron® Phase 2b chemotherapy...
Dogwood Therapeutics, Inc. Announces Conversion of Existing $19.5M in Debt to Equity, Strengthening Balance Sheet Moving Forward
March 12, 2025 08:30 ET
|
Dogwood Therapeutics, Inc.
ATLANTA, March 12, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a development-stage biopharmaceutical company focused on advancing first-in-class,...
Petvivo Holdings, Inc. and Digital Landia Corp. Announce Groundbreaking Strategic Alliance Agreement to Pioneer Agentic AI for Animal Communication
March 03, 2025 08:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, March 03, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) (the "Company" or “PetVivo”) an emerging biomedical device company focused on the...
Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.
February 21, 2025 07:00 ET
|
Nutriband Inc.
Issued new Trademark
PetVivo Reports Fiscal Q3 2025 Results
February 14, 2025 15:10 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Feb. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), a leading biomedical company delivering innovative therapeutics and medical devices for...
PetVivo Signs Exclusive Sales and Marketing Agreement with VetStem for PrecisePRP® Canine and Equine Products
February 14, 2025 08:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, Feb. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), a leader in innovative veterinary medical solutions, has entered into an Exclusive License...
Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
February 13, 2025 07:00 ET
|
Nutriband Inc.
Partnership Agreement
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024
February 11, 2025 10:15 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Feb. 11, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV and OTCPINK: PETVW), an emerging biomedical device company focused on the commercialization of innovative...
Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board
February 11, 2025 09:00 ET
|
Nutriband Inc.
ORLANDO, Fla., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (the “Company”)(NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced World and European...